ESC 2024 - Muthiah Vaduganathan shares the findings from FINE-HEART, a pooled integrated analysis of 3 pivotal RCTs of finerenone across the spectrum of CKM syndrome. “We believe that these data were compelling”, says Muthiah Vaduganathan.
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
ESC 2024 - Muthiah Vaduganathan shares the findings from FINE-HEART, a pooled integrated analysis of 3 pivotal RCTs of finerenone across the spectrum of CKM syndrome. “We believe that these data were compelling”, says Muthiah Vaduganathan.
This video was recorded during the ESC Congress 2024 in London, UK.
Mathiah Vaduganathan is a cardiologist at Brigham and Women's Hospital and faculty at Harvard Medical School, Boston, MA, US.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of FINE-HEART
Release date: 1 September 2024
ESC 2024 - Muthiah Vaduganathan shares the findings from FINE-HEART, a pooled integrated analysis of 3 pivotal RCTs of finerenone across the spectrum of CKM syndrome. “We believe that these data were compelling”, says Muthiah Vaduganathan.
This video was recorded during the ESC Congress 2024 in London, UK.
Mathiah Vaduganathan is a cardiologist at Brigham and Women's Hospital and faculty at Harvard Medical School, Boston, MA, US.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of FINE-HEART
Release date: 1 September 2024
Stay current with the best on medical education
